• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
CRaTER enrichment for on-target gene editing enables generation of variant libraries in hiPSCs.CRaTER 富集可实现 hiPSC 中靶基因编辑,从而生成变体文库。
J Mol Cell Cardiol. 2023 Jun;179:60-71. doi: 10.1016/j.yjmcc.2023.03.017. Epub 2023 Apr 3.
2
CRaTER enrichment for on-target gene-editing enables generation of variant libraries in hiPSCs.用于靶向基因编辑的CRaTER富集技术能够在人诱导多能干细胞中生成变异文库。
bioRxiv. 2023 Jan 26:2023.01.25.525582. doi: 10.1101/2023.01.25.525582.
3
Multiplexed Functional Assessments of Variants in Human Cardiomyocytes.高通量功能性评估人类心肌细胞中的变异。
Circ Genom Precis Med. 2024 Apr;17(2):e004377. doi: 10.1161/CIRCGEN.123.004377. Epub 2024 Feb 16.
4
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.使用 CRISPR/Cas9 基因编辑的同源诱导多能干细胞研究 MYH7 基因中 p.M659I(c.1977G > A)意义不明变异对肥厚型心肌病发病机制的影响。
Int J Mol Sci. 2024 Aug 9;25(16):8695. doi: 10.3390/ijms25168695.
5
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.
6
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.肥厚型心肌病的同基因模型揭示了不同的表型和机制驱动的治疗方法。
J Mol Cell Cardiol. 2020 Aug;145:43-53. doi: 10.1016/j.yjmcc.2020.06.003. Epub 2020 Jun 10.
7
Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.MYH7 基因突变诱导多能干细胞衍生的心肌细胞中增强的肌球蛋白细丝钙敏感性加重异常钙处理和舒张功能障碍。
Cell Calcium. 2024 Jan;117:102822. doi: 10.1016/j.ceca.2023.102822. Epub 2023 Nov 8.
8
Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of E848G Hypertrophic Cardiomyopathy.心肌细胞凋亡与 E848G 肥厚型心肌病干细胞模型中的收缩功能障碍有关。
Int J Mol Sci. 2023 Mar 3;24(5):4909. doi: 10.3390/ijms24054909.
9
Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.从携带 MYH7 R403L 突变的严重肥厚型心肌病患者和同源 CRISPR/Cas9 校正对照中生成 iPSC 系。
Stem Cell Res. 2021 Apr;52:102245. doi: 10.1016/j.scr.2021.102245. Epub 2021 Feb 11.
10
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.CRISPR/Cas9 编辑人多能干细胞诱导的心肌细胞模型揭示心律失常、收缩力减弱和能量耗竭可能成为肥厚型心肌病的治疗靶点。
Eur Heart J. 2018 Nov 14;39(43):3879-3892. doi: 10.1093/eurheartj/ehy249.

引用本文的文献

1
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.创建一个变异效应图谱,以解析意义未明的变异并指导心血管医学。
Nat Rev Cardiol. 2025 Sep 1. doi: 10.1038/s41569-025-01201-7.
2
Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects.基于图像的汇总表型分析揭示了多维度、疾病特异性的变异效应。
bioRxiv. 2025 Jul 5:2025.07.03.663081. doi: 10.1101/2025.07.03.663081.
3
Scaled multidimensional assays of variant effect identify sequence-function relationships in hypertrophic cardiomyopathy.变异效应的规模化多维分析确定肥厚型心肌病中的序列-功能关系。
bioRxiv. 2025 May 27:2025.05.23.655878. doi: 10.1101/2025.05.23.655878.
4
Emerging applications of gene editing technologies for the development of climate-resilient crops.基因编辑技术在培育气候适应型作物方面的新兴应用。
Front Genome Ed. 2025 Mar 10;7:1524767. doi: 10.3389/fgeed.2025.1524767. eCollection 2025.
5
STRAIGHT-IN: a platform for rapidly generating panels of genetically modified human pluripotent stem cell lines.直接导入:一个用于快速生成转基因人类多能干细胞系文库的平台。
Nat Protoc. 2024 Aug 23. doi: 10.1038/s41596-024-01039-2.
6
Multiplexed Functional Assessments of Variants in Human Cardiomyocytes.高通量功能性评估人类心肌细胞中的变异。
Circ Genom Precis Med. 2024 Apr;17(2):e004377. doi: 10.1161/CIRCGEN.123.004377. Epub 2024 Feb 16.

本文引用的文献

1
STRAIGHT-IN enables high-throughput targeting of large DNA payloads in human pluripotent stem cells.STRAIGHT-IN 可实现人类多能干细胞中高通量的大片段 DNA 靶向。
Cell Rep Methods. 2022 Sep 22;2(10):100300. doi: 10.1016/j.crmeth.2022.100300. eCollection 2022 Oct 24.
2
Biallelic and gene-wide genomic substitution for endogenous intron and retroelement mutagenesis in human cells.在人类细胞中进行内源性内含子和反转元件诱变的双等位基因和全基因组置换。
Nat Commun. 2022 Jul 21;13(1):4219. doi: 10.1038/s41467-022-31982-1.
3
Generation and genetic repair of two human induced pluripotent cell lines from patients with Epidermolysis Bullosa simplex and dilated cardiomyopathy associated with a heterozygous mutation in the translation initiation codon of KLHL24.从单纯性大疱性表皮松解症和扩张型心肌病患者中产生两个诱导多能干细胞系,并对与KLHL24翻译起始密码子杂合突变相关的基因进行修复。
Stem Cell Res. 2021 Dec;57:102582. doi: 10.1016/j.scr.2021.102582. Epub 2021 Oct 21.
4
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.利用 CRISPR 编辑的 iPSCs 破译意义不明变体的致病性。
Trends Genet. 2021 Dec;37(12):1109-1123. doi: 10.1016/j.tig.2021.08.009. Epub 2021 Sep 8.
5
ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes.ERRγ通过在人诱导多能干细胞衍生的心肌细胞中形成T小管来增强心脏成熟。
Nat Commun. 2021 Jun 21;12(1):3596. doi: 10.1038/s41467-021-23816-3.
6
A versatile platform for locus-scale genome rewriting and verification.一种用于基因座尺度基因组重写和验证的多功能平台。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2023952118.
7
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the locus as not an entirely safe harbour.CRISPR-Cas9靶向转基因的可变表达和沉默表明该位点并非完全安全。
F1000Res. 2019 Nov 12;8:1911. doi: 10.12688/f1000research.19894.2. eCollection 2019.
8
Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.使用诱导多能干细胞衍生的心肌细胞进行心脏疾病机制建模:进展、前景与挑战。
Int J Mol Sci. 2020 Jun 19;21(12):4354. doi: 10.3390/ijms21124354.
9
Silencing of ameliorates disease phenotypes in human iPSC-cardiomyocytes.沉默 可改善人诱导多能干细胞心肌细胞的疾病表型。
Physiol Genomics. 2020 Jul 1;52(7):293-303. doi: 10.1152/physiolgenomics.00021.2020. Epub 2020 Jun 22.
10
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.肥厚型心肌病的同基因模型揭示了不同的表型和机制驱动的治疗方法。
J Mol Cell Cardiol. 2020 Aug;145:43-53. doi: 10.1016/j.yjmcc.2020.06.003. Epub 2020 Jun 10.

CRaTER 富集可实现 hiPSC 中靶基因编辑,从而生成变体文库。

CRaTER enrichment for on-target gene editing enables generation of variant libraries in hiPSCs.

机构信息

Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA 98109, USA; Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA; Department of Medicine/Cardiology, University of Washington, Seattle, WA 98109, USA.

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

出版信息

J Mol Cell Cardiol. 2023 Jun;179:60-71. doi: 10.1016/j.yjmcc.2023.03.017. Epub 2023 Apr 3.

DOI:
10.1016/j.yjmcc.2023.03.017
PMID:37019277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10208587/
Abstract

Standard transgenic cell line generation requires screening 100-1000s of colonies to isolate correctly edited cells. We describe CRISPRa On-Target Editing Retrieval (CRaTER) which enriches for cells with on-target knock-in of a cDNA-fluorescent reporter transgene by transient activation of the targeted locus followed by flow sorting to recover edited cells. We show CRaTER recovers rare cells with heterozygous, biallelic-editing of the transcriptionally-inactive MYH7 locus in human induced pluripotent stem cells (hiPSCs), enriching on average 25-fold compared to standard antibiotic selection. We leveraged CRaTER to enrich for heterozygous knock-in of a library of variants in MYH7, a gene in which missense mutations cause cardiomyopathies, and recovered hiPSCs with 113 different variants. We differentiated these hiPSCs to cardiomyocytes and show MHC-β fusion proteins can localize as expected. Additionally, single-cell contractility analyses revealed cardiomyocytes with a pathogenic, hypertrophic cardiomyopathy-associated MYH7 variant exhibit salient HCM physiology relative to isogenic controls. Thus, CRaTER substantially reduces screening required for isolation of gene-edited cells, enabling generation of functional transgenic cell lines at unprecedented scale.

摘要

标准的转基因细胞系生成需要筛选 100-1000 个菌落以分离正确编辑的细胞。我们描述了 CRISPRa On-Target Editing Retrieval(CRaTER),它通过靶向基因座的瞬时激活来富集具有 cDNA-荧光报告基因的靶向敲入的细胞,然后通过流式分选来回收编辑的细胞。我们表明,CRaTER 从人诱导多能干细胞(hiPSC)中转录失活的 MYH7 基因座的杂合子、双等位基因编辑的稀有细胞中回收,与标准抗生素选择相比,平均富集 25 倍。我们利用 CRaTER 富集 MYH7 基因中的变体文库的杂合敲入,该基因中的错义突变导致心肌病,并且回收了具有 113 种不同变体的 hiPSC。我们将这些 hiPSC 分化为心肌细胞,并表明 MHC-β 融合蛋白可以按预期定位。此外,单细胞收缩性分析显示,与同基因对照相比,具有致病性、肥厚型心肌病相关 MYH7 变体的心肌细胞表现出显著的 HCM 生理学特征。因此,CRaTER 大大减少了分离基因编辑细胞所需的筛选,从而能够以前所未有的规模生成功能性转基因细胞系。